Overall, DNase activity is reduced in the serum of SLE/LN patients, while circulating DNase I levels are normal, suggesting that DNase 1L3-serum-level modification is directly responsible for the reduced DNase activity [10], determining the imbalance in extracellular DNA responsible for anti-ds DNA production. Here, DNASE1L3 is linked to lobular neoplasia.